|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
|
KR20190064600A
(ko)
|
2016-09-23 |
2019-06-10 |
듀크 유니버시티 |
Lcst 거동을 갖는 비구조화된 비-반복적 폴리펩티드
|
|
EP3658168A4
(en)
|
2017-06-30 |
2021-07-14 |
Duke University |
ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-RESPONDING BIOPOLYMER NETWORKS
|
|
WO2019147954A1
(en)
|
2018-01-26 |
2019-08-01 |
Duke University |
Albumin binding peptide-drug (aibiped) conjugates and methods of making and using same
|
|
WO2019213150A1
(en)
|
2018-04-30 |
2019-11-07 |
Duke University |
Stimuli-responsive peg-like polymer-based drug delivery platform
|
|
WO2020051541A1
(en)
|
2018-09-07 |
2020-03-12 |
Duke University |
Nanoparticulate drug delivery systems
|
|
DK3864163T3
(da)
|
2018-10-09 |
2024-05-06 |
Univ British Columbia |
Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
|
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
|
US12534435B2
(en)
*
|
2020-03-27 |
2026-01-27 |
Generation Bio Co. |
Lipids and nanoparticle compositions thereof
|
|
MX2023012369A
(es)
|
2021-04-20 |
2024-01-08 |
Generation Bio Co |
Lípidos catiónicos y composiciones de estos.
|
|
CA3215963A1
(en)
*
|
2021-05-28 |
2022-12-01 |
Yaoxin LIN |
Lipid compound and use thereof in delivery of nucleic acid
|
|
CN117642380A
(zh)
*
|
2021-06-14 |
2024-03-01 |
世代生物公司 |
阳离子脂质及其组合物
|
|
US20250281596A1
(en)
*
|
2021-09-28 |
2025-09-11 |
Seqirus Inc. |
Ionizable cationic compound
|
|
EP4422605A4
(en)
*
|
2021-10-25 |
2025-06-18 |
Duke University |
Poegma-based lipid nanoparticles
|
|
US20250213478A1
(en)
*
|
2022-03-28 |
2025-07-03 |
Nof Corporation |
Cationic lipid having disulfide bond, lipid membrane structure including same, nucleic acid introduction agent and pharmaceutical composition containing any one of same, method for introducing nucleic acid into cell or target cell, and method for producing cellular pharmaceutical
|
|
CN114685784B
(zh)
*
|
2022-04-26 |
2023-09-15 |
北京清科胜因生物科技有限公司 |
一种用于核酸递送的聚(2-噁唑啉)脂质与脂质纳米颗粒及应用
|
|
WO2023239756A1
(en)
*
|
2022-06-07 |
2023-12-14 |
Generation Bio Co. |
Lipid nanoparticle compositions and uses thereof
|
|
CN115105584B
(zh)
*
|
2022-06-28 |
2023-03-31 |
长春生物制品研究所有限责任公司 |
一种卡式瓶多剂量笔式注射组合包装的干扰素注射液
|
|
WO2024037577A1
(en)
*
|
2022-08-18 |
2024-02-22 |
Suzhou Abogen Biosciences Co., Ltd. |
Composition of lipid nanoparticles
|
|
CN120112275A
(zh)
*
|
2022-08-25 |
2025-06-06 |
俄亥俄州创新基金会 |
用于递送包括核酸的活性剂的组合物和方法
|
|
US20240150306A1
(en)
*
|
2022-09-27 |
2024-05-09 |
Reinvigoron Theratech, Inc. |
Compounds with cleavable disulfide moieties
|
|
JP2025535566A
(ja)
*
|
2022-11-08 |
2025-10-24 |
サムヤン ホールディングス コーポレイション |
カチオン性脂質及びその製造方法
|
|
EP4626402A1
(en)
|
2022-12-01 |
2025-10-08 |
Generation Bio Co. |
Lipid nanoparticles comprising nucleic acids and lipid-anchored polymers
|
|
EP4704855A1
(en)
*
|
2023-04-26 |
2026-03-11 |
Saliogen Therapeutics, Inc. |
Lipid nanoparticle (lnp) formulations
|
|
EP4719352A1
(en)
|
2023-05-31 |
2026-04-08 |
Capstan Therapeutics, Inc. |
Lipid nanoparticle formulations and compositions
|
|
WO2025043146A2
(en)
*
|
2023-08-24 |
2025-02-27 |
Molecular Axiom Inc. |
Lipid nanoparticle compositions and methods of using same
|
|
WO2025064850A1
(en)
|
2023-09-22 |
2025-03-27 |
BioNTech SE |
Rna constructs with n-terminal degrons to enhance an immune response
|
|
FR3155424A1
(fr)
|
2023-11-15 |
2025-05-23 |
BioNTech SE |
Compositions immunogènes contre le sars-cov-2
|
|
WO2025106754A1
(en)
|
2023-11-15 |
2025-05-22 |
BioNTech SE |
Coronavirus vaccine
|
|
WO2025149492A1
(en)
|
2024-01-08 |
2025-07-17 |
BioNTech SE |
Rna encoding an immune inhibitory il-1 family member
|
|
WO2025166238A1
(en)
*
|
2024-01-31 |
2025-08-07 |
Orna Therapeutics, Inc. |
Fast-shedding polyethylene glycol lipids
|
|
WO2025178465A1
(ko)
*
|
2024-02-19 |
2025-08-28 |
주식회사 메디치바이오 |
신규한 이온화 지질 및 이를 이용한 지질 나노입자 조성물
|
|
WO2025230906A1
(en)
*
|
2024-04-29 |
2025-11-06 |
Saliogen Therapeutics, Inc. |
Lipid nanoparticle (lnp) formulations
|
|
WO2025237830A1
(en)
*
|
2024-05-15 |
2025-11-20 |
Evonik Operations Gmbh |
Polyoxyalkylene-1,2-di(alkyloxy)propanoxy-carbonylaminopropyl compounds, wherein the polyoxyalkylene is a poly(ethylene oxide) having c1 to c3-alkyloxymethyl side chains
|
|
WO2025255027A1
(en)
*
|
2024-06-03 |
2025-12-11 |
Flagship Labs 114, Inc. |
Lipid nanoparticles for topical delivery
|
|
WO2026047603A1
(en)
|
2024-08-28 |
2026-03-05 |
BioNTech SE |
Sars-cov-2 immunogenic compositions
|
|
WO2026057626A1
(en)
|
2024-09-11 |
2026-03-19 |
BioNTech SE |
Peptidoglycan hydrolases having multiple enzymatically active domains
|
|
WO2026057625A1
(en)
|
2024-09-11 |
2026-03-19 |
BioNTech SE |
Peptidoglycan hydrolases having a chap domain with engineered active site
|
|
WO2026068864A1
(en)
|
2024-09-30 |
2026-04-02 |
BioNTech SE |
Engineered ch1 and cl domains for the prevention of chain mispairing
|
|
WO2026082899A2
(en)
|
2024-10-16 |
2026-04-23 |
BioNTech SE |
Rna for preventing or treating tuberculosis
|
|
WO2026090590A1
(en)
*
|
2024-10-25 |
2026-04-30 |
Remedium Bio, Inc. |
Nanoparticle formulations for the delivery of dna to adipose tissue
|
|
WO2026119817A1
(en)
|
2024-12-02 |
2026-06-11 |
BioNTech SE |
Agents and methods for targeted delivery of immune effector cells
|
|
WO2026125598A1
(en)
|
2024-12-13 |
2026-06-18 |
BioNTech SE |
Measuring nucleic acid integrity
|
|
WO2026125590A1
(en)
|
2024-12-13 |
2026-06-18 |
BioNTech SE |
Measuring nucleic acid integrity
|
|
WO2026148356A1
(en)
|
2025-01-06 |
2026-07-09 |
BioNTech SE |
Coronavirus and influenza immunogenic combinations
|
|
WO2026150132A1
(en)
|
2025-01-12 |
2026-07-16 |
BioNTech SE |
Combination therapy comprising an rna cancer vaccine and a multispecific binding agent targeting pd-1/pd-l1 and vegf/vegfr for cancer treatment
|
|
WO2026162682A1
(en)
|
2025-01-29 |
2026-08-06 |
BioNTech SE |
Compositions for delivery of plasmodium rh5 antigens and related methods
|
|
WO2026162552A1
(en)
|
2025-01-31 |
2026-08-06 |
BioNTech SE |
Agents and methods for targeted delivery to cells
|
|
CN121421963B
(zh)
*
|
2026-01-04 |
2026-05-05 |
广州隽沐生物科技股份有限公司 |
一种用于难溶性活性经皮黏膜给药的装配材料及制备方法
|